C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2002
11/13/2002	EP0618807B1 A stabilized pharmaceutical formulation comprising growth hormone and histidine
11/13/2002	EP0606452B1 Vector vaccines of recombinant feline herpesvirus
11/13/2002	EP0584284B9 Recombinant dna-derived cholera toxin subunit analogs
11/13/2002	EP0449958B2 Meningococcal class 1 outer-membrane protein vaccine
11/13/2002	CN1379820A Lentiviral vectors for preparation of immunotherapeutical compositions
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379816A Human G-protein coupled receptor
11/13/2002	CN1379815A BAFF receptor (BCMA), immunoregulatory agent
11/13/2002	CN1379786A Modified peptides and peptidomimetics for use in immunotherapy
11/13/2002	CN1379783A Methods for increasing plant cell proliferation by functionally inhibiting plant cyclin inhibitor gene
11/13/2002	CN1379685A Novel method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and beta integrins
11/13/2002	CN1379683A 疫苗 Vaccine
11/13/2002	CN1379682A Use of outer membrane protein of enterobacterium associated with RSV immunogeni peptide for preparing vaccines for intranasal administration
11/13/2002	CN1379680A New class of bioactive glycoprotein
11/13/2002	CN1379092A Human cyclophilin coding sequence and its preparing process and application
11/13/2002	CN1379091A Refractory arginine inhibitor gene and its polypeptide coded by it and preparing process
11/13/2002	CN1379042A Scorpion peptide for treating arrhythmia and its preparing process and application
11/13/2002	CN1379041A Cytotoxin T lymphocyte
11/13/2002	CN1379039A Control of mutational lethal gene associated with synthesis of arabidopsis' chlorophyll
11/13/2002	CN1379038A Specific gene associated with stunt of arabidopsis
11/13/2002	CN1094044C Isoflavone depleted vegetable protein material and vegetable protein composition containing isoflavone material
11/12/2002	US6479734 DNA fragment responsive to low temperatures and a plant transformed with the DNA fragment
11/12/2002	US6479731 Pi-ta gene conferring fungal disease resistance to plants
11/12/2002	US6479729 Mouse model for ocular neovascularization
11/12/2002	US6479654 Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF
11/12/2002	US6479653 Compositions and method for regulation of transcription
11/12/2002	US6479652 Oligonucleotide mediated nucleic acid recombination
11/12/2002	US6479643 Single chain analogs of the TGF-β superfamily (morphons)
11/12/2002	US6479642 Cortistatin: neuropeptides
11/12/2002	US6479638 Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor
11/12/2002	US6479637 Hemoglobin-haptoglobin complexes
11/12/2002	US6479636 Extracting the sugarcane to obtai cane pression juice; cleaning pression sugarcane juice to remove particulate matter; adjusting; transmitting through membrane separation system to produce apt fractions
11/12/2002	US6479635 Receptor activator of NF-κB
11/12/2002	US6479634 IL-B30 proteins
11/12/2002	US6479633 Chemokine alpha 2
11/12/2002	US6479632 Tumor necrosis factor inhibitory protein and its purification
11/12/2002	US6479630 Human purinergic P2U receptor
11/12/2002	US6479626 Poly zinc finger proteins with improved linkers
11/12/2002	US6479464 Polypeptide comprising of the following 29 amino acid composition: 6g's, 2f's, 2l's, 1w, 4r's, 2e's, 2n's, 3k's, 1t, 1s, 1a, 1y, 1m, 1c, and 1i, and additional cationic residues to provide a net number of positive charges of at least 8
11/12/2002	US6479460 Pseudopeptidic osteogenic growth polypeptide
11/12/2002	US6479459 Cytokine designated lerk-5
11/12/2002	US6479291 Cytoplasmic inhibition of gene expression by viral RNA
11/12/2002	US6479282 Hbc expression and diagnostic and therapeutic uses
11/12/2002	US6479281 Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof
11/12/2002	US6479279 Episomal vectors and uses thereof
11/12/2002	US6479265 Catalytic antibodies which hydrolyze primary amides and methods for eliciting and use of such antibodies
11/12/2002	US6479261 Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells
11/12/2002	US6479260 Cold-inducible expression vector
11/12/2002	US6479259 Human peripheral nerve, tetrodotoxin-resistant sodium channel α-subunit polypeptide
11/12/2002	US6479258 Non-stochastic generation of genetic vaccines
11/12/2002	US6479257 Method of activating protein and an apparatus therefor
11/12/2002	US6479256 Lectomedin materials and methods
11/12/2002	US6479255 Polynucleotides encoding human FRP and fragments thereof
11/12/2002	US6479254 Polypeptide for use in treatment of lymphadenopathy, autoimmune disease and graft versus host disease; antitumor agents
11/12/2002	US6479253 Serine protease inhibitor nucleic acid molecules and uses thereof
11/12/2002	US6479250 Eck receptor ligands
11/12/2002	US6479238 Polymorphic markers of the LSR gene
11/12/2002	US6479078 Substantially crystalline form of melagatran
11/12/2002	US6479055 Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
11/12/2002	US6479049 Methods and compositions for the dry powder formulation of interferons
11/12/2002	US6479047 Lymphotactin as an adjuvant
11/12/2002	US6479032 Calcitonin receptor binding reagents
11/12/2002	US6478749 Diagnostic kit for skin tests, and method
11/12/2002	CA2220684C Process for controlling sialylation of proteins produced by mammalian cell culture
11/12/2002	CA2204535C Molecules that home to a selected organ or tissue in vivo and methods of identifying same
11/12/2002	CA2169635C Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
11/12/2002	CA2138647C Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
11/12/2002	CA2101227C Chlorophyll and bacteriochlorophyll derivatives and pharmaceutical compositions containing them
11/12/2002	CA2091061C Dna fragments coding for a bacteriophage-resistant mechanism
11/12/2002	CA2065245C Recombinant negative strand rna virus expression systems and vaccines
11/12/2002	CA2062820C Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
11/12/2002	CA2055963C Chimeric fibroblast growth factor
11/10/2002	CA2382463A1 Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
11/08/2002	CA2387391A1 Hu antigen-derived peptides and uses thereof
11/07/2002	WO2002088752A2 Method for detecting activator or inhibitor compounds of receptors of the family of the insulin receptor using an isolated chimeric receptor
11/07/2002	WO2002088741A1 Detection of candida
11/07/2002	WO2002088390A1 Method and kit for diagnosing gh deficiency
11/07/2002	WO2002088380A2 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
11/07/2002	WO2002088378A2 66784, a novel human potassium channel and uses therefor
11/07/2002	WO2002088377A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/07/2002	WO2002088375A2 Compositions and methods relating to breast specific genes and proteins
11/07/2002	WO2002088369A1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants
11/07/2002	WO2002088367A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus
11/07/2002	WO2002088361A2 Haemophilus influenzae antigens
11/07/2002	WO2002088360A2 Haemophilus influenzae antigens
11/07/2002	WO2002088359A1 Modification of plant defense, disease/pest resistance and protein storage
11/07/2002	WO2002088358A2 Human fibroblast growth factor-related compositions
11/07/2002	WO2002088357A2 84242, 8035, 55304, 52999, and 21999, novel human proteins and methods of use thereof
11/07/2002	WO2002088356A1 Novel g protein-coupled receptor protein and dna thereof
11/07/2002	WO2002088355A1 Novel guanosine triphosphate-binding protein-coupled recepotr place 6002312 and its gene and production and use of the same
11/07/2002	WO2002088354A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002	WO2002088352A2 Schwann cell specific enhancer and methods of use thereof
11/07/2002	WO2002088351A1 Modified organs and cells for xenotransplantation
11/07/2002	WO2002088347A2 Aav helper plasmids for helper virus-free packaging and pseudo typification of aav vectors
11/07/2002	WO2002088346A2 A system for inducible expression in eukaryotic cells
11/07/2002	WO2002088339A2 Bursal disease virus-like particles
11/07/2002	WO2002088338A2 Method for replicating the hepatitis c virus
11/07/2002	WO2002088334A1 Chimeric immunoreceptor useful in treating human cancers
11/07/2002	WO2002088327A1 Methods for viral oncoapoptosis in cancer therapy
11/07/2002	WO2002088322A2 Cell adhesion and extracellular matrix proteins

1 ... 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 ... 2916